260 related articles for article (PubMed ID: 19196477)
1. Inhibition of complement C5a prevents breakdown of the blood-brain barrier and pituitary dysfunction in experimental sepsis.
Flierl MA; Stahel PF; Rittirsch D; Huber-Lang M; Niederbichler AD; Hoesel LM; Touban BM; Morgan SJ; Smith WR; Ward PA; Ipaktchi K
Crit Care; 2009; 13(1):R12. PubMed ID: 19196477
[TBL] [Abstract][Full Text] [Related]
2. C5a, a therapeutic target in sepsis.
Guo RF; Ward PA
Recent Pat Antiinfect Drug Discov; 2006 Jan; 1(1):57-65. PubMed ID: 18221134
[TBL] [Abstract][Full Text] [Related]
3. Sepsis-associated delirium: the pro and con of C5a blockade.
Annane D
Crit Care; 2009; 13(2):135. PubMed ID: 19439043
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of C5a blockade in sepsis.
Czermak BJ; Sarma V; Pierson CL; Warner RL; Huber-Lang M; Bless NM; Schmal H; Friedl HP; Ward PA
Nat Med; 1999 Jul; 5(7):788-92. PubMed ID: 10395324
[TBL] [Abstract][Full Text] [Related]
5. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
[TBL] [Abstract][Full Text] [Related]
6. C5a alters blood-brain barrier integrity in experimental lupus.
Jacob A; Hack B; Chiang E; Garcia JG; Quigg RJ; Alexander JJ
FASEB J; 2010 Jun; 24(6):1682-8. PubMed ID: 20065106
[TBL] [Abstract][Full Text] [Related]
7. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
[TBL] [Abstract][Full Text] [Related]
8. Effect of magnesium sulfate administration on blood-brain barrier in a rat model of intraperitoneal sepsis: a randomized controlled experimental study.
Esen F; Erdem T; Aktan D; Orhan M; Kaya M; Eraksoy H; Cakar N; Telci L
Crit Care; 2005 Feb; 9(1):R18-23. PubMed ID: 15693962
[TBL] [Abstract][Full Text] [Related]
9. C5a alters blood-brain barrier integrity in a human in vitro model of systemic lupus erythematosus.
Mahajan SD; Parikh NU; Woodruff TM; Jarvis JN; Lopez M; Hennon T; Cunningham P; Quigg RJ; Schwartz SA; Alexander JJ
Immunology; 2015 Sep; 146(1):130-43. PubMed ID: 26059553
[TBL] [Abstract][Full Text] [Related]
10. Anti-complement strategies in experimental sepsis.
Ward PA; Riedemann NC; Guo RF; Huber-Lang M; Sarma JV; Zetoune FS
Scand J Infect Dis; 2003; 35(9):601-3. PubMed ID: 14620141
[TBL] [Abstract][Full Text] [Related]
11. A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis.
Hoehlig K; Maasch C; Shushakova N; Buchner K; Huber-Lang M; Purschke WG; Vater A; Klussmann S
Mol Ther; 2013 Dec; 21(12):2236-46. PubMed ID: 23887360
[TBL] [Abstract][Full Text] [Related]
12. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of enhanced lung injury during sepsis.
Czermak BJ; Breckwoldt M; Ravage ZB; Huber-Lang M; Schmal H; Bless NM; Friedl HP; Ward PA
Am J Pathol; 1999 Apr; 154(4):1057-65. PubMed ID: 10233844
[TBL] [Abstract][Full Text] [Related]
14. Role of C5a in multiorgan failure during sepsis.
Huber-Lang M; Sarma VJ; Lu KT; McGuire SR; Padgaonkar VA; Guo RF; Younkin EM; Kunkel RG; Ding J; Erickson R; Curnutte JT; Ward PA
J Immunol; 2001 Jan; 166(2):1193-9. PubMed ID: 11145701
[TBL] [Abstract][Full Text] [Related]
15. Divergent signaling pathways in phagocytic cells during sepsis.
Guo RF; Riedemann NC; Sun L; Gao H; Shi KX; Reuben JS; Sarma VJ; Zetoune FS; Ward PA
J Immunol; 2006 Jul; 177(2):1306-13. PubMed ID: 16818791
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulins prevent the breakdown of the blood-brain barrier in experimentally induced sepsis.
Esen F; Senturk E; Ozcan PE; Ahishali B; Arican N; Orhan N; Ekizoglu O; Kucuk M; Kaya M
Crit Care Med; 2012 Apr; 40(4):1214-20. PubMed ID: 22202704
[TBL] [Abstract][Full Text] [Related]
17. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.
Laudes IJ; Chu JC; Sikranth S; Huber-Lang M; Guo RF; Riedemann N; Sarma JV; Schmaier AH; Ward PA
Am J Pathol; 2002 May; 160(5):1867-75. PubMed ID: 12000738
[TBL] [Abstract][Full Text] [Related]
18. Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis.
Riedemann NC; Guo RF; Hollmann TJ; Gao H; Neff TA; Reuben JS; Speyer CL; Sarma JV; Wetsel RA; Zetoune FS; Ward PA
FASEB J; 2004 Feb; 18(2):370-2. PubMed ID: 14688199
[TBL] [Abstract][Full Text] [Related]
19. Platonin preserves blood-brain barrier integrity in septic rats.
Yeh CT; Kao MC; Chen CH; Huang CJ
Acta Anaesthesiol Taiwan; 2015 Mar; 53(1):12-5. PubMed ID: 25791838
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a functional role of the second C5a receptor C5L2.
Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
